PDS Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71M Buy
19,285
+951
+5% +$222K 0.31% 49
2025
Q4
$3.79M Sell
18,334
-665
-4% -$132K 0.25% 52
2025
Q3
$3.52M Buy
18,999
+656
+4% +$112K 0.24% 53
2025
Q2
$2.8M Sell
18,343
-243
-1% -$37.4K 0.21% 60
2025
Q1
$3.08M Buy
18,586
+1,589
+9% +$249K 0.26% 52
2024
Q4
$2.46M Buy
16,997
+2,155
+15% +$334K 0.22% 56
2024
Q3
$2.41M Buy
14,842
+729
+5% +$116K 0.22% 58
2024
Q2
$2.06M Sell
14,113
-1,006
-7% -$150K 0.21% 59
2024
Q1
$2.39M Buy
15,119
+353
+2% +$56.2K 0.25% 51
2023
Q4
$2.31M Sell
14,766
-30
-0.2% -$4.6K 0.26% 49
2023
Q3
$2.3M Sell
14,796
-654
-4% -$108K 0.3% 48
2023
Q2
$2.56M Buy
15,450
+1,037
+7% +$167K 0.33% 46
2023
Q1
$2.23M Buy
14,413
+4,030
+39% +$651K 0.31% 47
2022
Q4
$1.83M Buy
10,383
+31
+0.3% +$5.35K 0.29% 44
2022
Q3
$1.69M Buy
10,352
+515
+5% +$87.1K 0.31% 45
2022
Q2
$1.75M Buy
9,837
+762
+8% +$136K 0.32% 47
2022
Q1
$1.61M Buy
9,075
+644
+8% +$110K 0.28% 48
2021
Q4
$1.44M Sell
8,431
-285
-3% -$46.7K 0.28% 46
2021
Q3
$1.41M Buy
8,716
+324
+4% +$55.3K 0.32% 42
2021
Q2
$1.38M Buy
8,392
+739
+10% +$122K 0.34% 43
2021
Q1
$1.26M Buy
7,653
+293
+4% +$47.4K 0.37% 41
2020
Q4
$1.16M Buy
7,360
+148
+2% +$21.8K 0.4% 40
2020
Q3
$1.07M Buy
7,212
+441
+7% +$65.3K 0.44% 41
2020
Q2
$952K Buy
6,771
+917
+16% +$134K 0.43% 41
2020
Q1
$768K Buy
5,854
+606
+12% +$86K 0.49% 38
2019
Q4
$766K Buy
5,248
+8
+0.2% +$1.08K 0.48% 41
2019
Q3
$678K Buy
5,240
+374
+8% +$49.3K 0.47% 42
2019
Q2
$678K Buy
4,866
+449
+10% +$62.2K 0.5% 40
2019
Q1
$617K Buy
4,417
+346
+8% +$46.3K 0.48% 41
2018
Q4
$525K Buy
4,071
+398
+11% +$55.5K 0.45% 42
2018
Q3
$507K Buy
3,673
+357
+11% +$47.4K 0.43% 41
2018
Q2
$402K Sell
3,316
-64
-2% -$7.99K 0.4% 45
2018
Q1
$433K Hold
3,380
0.44% 42
2017
Q4
$472K Buy
+3,380
New +$471K 0.48% 41

Other funds holding JNJ

PDS Planning's JNJ Position: Q1 2026 in Review

PDS Planning increased its Johnson & Johnson (JNJ) stake by 5.2% in Q1 2026, buying an estimated $222K and bringing the position to 19,285 shares worth $4.71M. The position accounts for 0.31% of the portfolio, ranked #49.

PDS Planning first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • PDS Planning held 19,285 shares of Johnson & Johnson worth $4.71M as of Q1 2026.
  • PDS Planning bought 951 Johnson & Johnson shares in Q1 2026, an estimated $222K.
  • Johnson & Johnson made up 0.31% of PDS Planning's portfolio in Q1 2026, its #49 holding.
  • PDS Planning first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.